组蛋白
组蛋白脱乙酰基酶
重性抑郁障碍
组蛋白甲基转移酶
乙酰化
组蛋白脱乙酰基酶5
组蛋白甲基化
HDAC11型
组蛋白密码
组蛋白H2A
组蛋白脱乙酰基酶2
表观遗传学
医学
癌症研究
萧条(经济学)
抗抑郁药
生物
神经科学
心理学
遗传学
精神科
DNA甲基化
基因
基因表达
认知
核小体
作者
Mansi Wu,Xiaojuan Li,Chenyue Liu,Qiuyue Xu,Junqing Huang,Simeng Gu,Jiaxu Chen
出处
期刊:Current Neuropharmacology
[Bentham Science]
日期:2021-09-22
卷期号:20 (7): 1261-1277
被引量:1
标识
DOI:10.2174/1570159x19666210922150043
摘要
: Major depressive disorder (MDD) is a disease associated with many factors; specifically, environmental, genetic, psychological, and biological factors play critical roles. Recent studies have demonstrated that histone modification may occur in the human brain in response to severely stressful events, resulting in transcriptional changes and the development of MDD. In this review, we discuss five different histone modifications, histone methylation, histone acetylation, histone phosphorylation, histone crotonylation and histone β-hydroxybutyrylation, and their relationships with MDD. The utility of histone deacetylase (HDAC) inhibitors (HDACis) for MDD treatment is also discussed. As a large number of MDD patients in China have been treated with traditional Chineses medicine (TCM), we also discuss some TCM therapies, such as Xiaoyaosan (XYS), and their effects on histone modification. In summary, targeting histone modification may
科研通智能强力驱动
Strongly Powered by AbleSci AI